The effect of a memory screening program on the early diagnosis of Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 19, Issue 1, 2005, Pages 1-7

  Barker, Warren W ^a   Luis, Cheryl ^a,b   Harwood, Dylan ^a   Loewenstein, David ^a,b   Bravo, Marina ^a   Ownby, Ray ^a,b   Duara, Ranjan ^a,b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Early detection; Hispanic; Screening

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; DELUSION; EARLY DIAGNOSIS; ETHNOLOGY; FAMILY; FEMALE; GENDER; HALLUCINATION; HISPANIC; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; OUTPATIENT; PHYSICIAN; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; SCREENING; SELF REPORT; SYMPTOMATOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; COMORBIDITY; EARLY DIAGNOSIS; FEMALE; FLORIDA; HUMANS; MALE; MASS SCREENING; MEMORY DISORDERS; MENTAL STATUS SCHEDULE; MIDDLE AGED; PSYCHOMETRICS; PSYCHOTIC DISORDERS; REFERRAL AND CONSULTATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 16844363595     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000155380.63231.68     Document Type: Article

References (40)

1. Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119-1122.
2. Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain bank. Alzheimer Dis Assoc Disord. 2002;16:203-212.
3. Farlow M. A clinical overview of cholinesterase inhibitors in Alzheimer's disease. Int Psychogeriatr. 2002;14(Suppl 1):93-126.
4. Valcour VG, Masaki KH, Blanchette PL. Self-reported driving, cognitive status, and physician awareness of cognitive impairment. J Am Geriatr Soc. 2002;50:1265-1267.
5. Ross GW, Abbott RD, Petrovitch H, et al. Frequency and characteristics of silent dementia among elderly Japanese-American men: The Honolulu-Asia Aging Study. JAMA. 1997;277:800-805.
6. Doriswamy PM, Steffens DC, Pitchumoni S, et al. Early recognition of Alzheimer's Disease: What is Consensual? What is controversial? What is practical? J Clin Psychiatry. 1998;59(Suppl 13):6-18.
7. Knopman D, Donohue JA, Gutterman EM. Patterns of care in the early stages of Alzheimer's disease: impediments to timely diagnosis. J Am Geriatr Soc. 2000;48:300-304.
8. Werner P. Correlates of family caregivers' knowledge about Alzheimer's disease. Int J Geriatr Psychiatry. 2001;16:32-38.
9. Valcour VG, Masaki KH, Curb JD, et al. The detection of dementia in the primary care setting. Arch Intern Med. 2000;160:2964-2968.
10. Argüelles S, Loewenstein DA, Eisdorfer C, et al. Caregiver's judgements of the functional abilities of the Alzheimer's disease patient: The impact of caregiver's depression and perceived burden. J Geriatr Psychiatry Neurol. 2001;14:91-98.
11. Loewenstein DA, Arguelles S, Bravo M, et al. Caregiver's judgments of the functional abilities of the Alzheimer's disease patient: A comparison of proxy reports and objective measures. J Gerontol B Psychol Sci Soc Sci. 2001;56B:78-84.
12. Hooker K, Bowman SR, Coehlo DP, et al. Behavioral change in persons with dementia: relationships with mental and physical health of caregivers. J Gerontol B Psychol Sci Soc Sci. 2002;57:453-460.
13. Ortiz F, Fitten LJ. Barriers to healthcare access for cognitively impaired older Hispanics. Alzheimer Dis Assoc Disord. 2000;14:141-150.
14. Boustani M, Peterson B, Hanson L, et al. U.S. Preventive Services Task Force. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138:927-937.
15. Brodaty H, Clarke J, Ganguli M, et al. Screening for cognitive impairment in general practice: Toward a consensus. Alzheimer Dis Assoc Disord. 1998;12:1-13.
16. Patterson CJ, Gass DA. Screening for cognitive impairment and dementia in the elderly. Can J Neurol Sci. 2001;28(Suppl 1):S42-S51.
17. Harwood D, Barker W, Ownby R, et al. Memory complaints in the elderly: A comparative analysis of informant and subjects reports among Hispanics and white Non-Hispanics. Clin Gerontol. 1998;18:56-60.
18. Folstein M, Folstein S, McHugh P. Mini-mental state. A practical method for grading the cognitive state of patients for the physician. J Psychiatr Res. 1975;12:189-198.
19. Loewenstein DA, Barker WW, Harwood DG, et al. Utility of a modified mini-mental state examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders. Int J Geriatr Psychiatry. 2000;15:434-440.
20. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia: Lea and Febiger; 1983.
21. Harwood D, Barker WW, Ownby RL, et al. The association of Apolipoprotein-E (APO-E) genotype with symptoms of psychosis in Alzheimer's disease. Am J Geriatr Psychiatry. 1999;7:119-123.
22. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease. Neurology. 1984;34:939-944.
23. Duara R, Pascal S, Barker WW. Neuropathological verification of probable and possible Alzheimer's disease (AD) [abstract]. Ann Neurol. 1992;32:269.
24. Mungas D, Marshall SC, Weldon M, et al. Age and education correction of the Mini-Mental State Examination for English and Spanish-speaking elderly. Neurology. 1996;46:700-706.
25. Trinh NH, Hoblyn J, Mohanty S, et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA. 2003;289:210-216.
26. Cummings JL, Frank JC, Cherry D, et al. Guidelines for managing Alzheimer's disease: Part II. Treatment. Am Fam Physician. 2002;65:2525-2534.
27. Wimo A, Winblad B, Engedal K, et al. An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial. Dement Geriatr Cogn Disord. 2003;15:44-54.
28. Han L, Cole M, Bellavance F, et al. Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: a meta-analysis. Int Psychogeriatr. 2000;12:231-247.
29. Lawrence J, Davidoff D, Katt-Lloyd D, et al. A pilot program of improved methods for community-based screening for dementia. J Am Geriatr Soc. 2003;51:1072-1078.
30. Jost BC, Grossberg GT. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J Am Geriatr Soc. 1996;44:1078-1081.
31. Ripich DN, Petrill SA, Whitehouse PJ, et al. Gender differences in language of AD patients: a longitudinal study. Neurology. 1995;45:299-302.
32. Hebert LE, Wilson RS, Gilley DW, et al. Decline of language among women and men with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 2000;55:354-360.
33. Paulsen JS, Salmon DP, Thal LJ, et al. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology. 2000;54:1965-1971.
34. Leroi I, Voulgari A, Breitner JC, et al. The epidemiology of psychosis in dementia. Am J Geriatr Psychiatry. 2003;11:83-91.
35. Snowden LR, Cheung FK. Use of inpatent mental health services by members of ethnic minority groups. Am Psychol. 1990;45:347-355.
36. Hobbs FB, Damon BL. US Census Bureau. 65+ in the United States. P23-190 Current Population Reports: Special Studies; 1996.
37. Tang MX, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56:49-56.
38. Leung GM, Yeung RY, Chi I, et al. The economics of Alzheimer disease. Dement Geriatr Cogn Disord. 2003;15:34-43.
39. Werner P. Factors influencing intentions to seek a cognitive status examination: a study based on the Health Belief Model. Int J Geriatr Psychiatry. 2003;18:787-794.
40. Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry. 2000;15:983-991.